Location: Princeton, NJ
CIK: 0001388551 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 13, 2026
Total Value: $4.279M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GLD | SPDR GOLD TR | 6,964 | $2.76M | 64.5% | $310.70 | — | GOLD SHS | 78463V107 |
| BRK/B | BERKSHIRE HATHAWAY INC DEL | 710 | $357K | 8.3% | $409.76 | +21.4% | CL B NEW | 084670702 |
| SYRE | SPYRE THERAPEUTICS INC | 8,919 | $292K | 6.8% | $26.13 | 0.0% | COM NEW | 00773J202 |
| — | MIND MEDICINE MINDMED INC | 15,688 | $210K | 4.9% | $8.91 | — | COM NEW | 60255C885 |
| KYTX | KYVERNA THERAPEUTICS INC | 18,773 | $176K | 4.1% | $23.94 | -69.0% | COM | 501976104 |
| CMPX | COMPASS THERAPEUTICS INC | 29,495 | $158K | 3.7% | $3.22 | +43.5% | COM | 20454B104 |
| LXEO | LEXEO THERAPEUTICS INC | 13,943 | $138K | 3.2% | $13.31 | -31.4% | COM | 52886X107 |
| XFOR | X4 PHARMACEUTICALS INC | 15,557 | $62,227 | 1.5% | $3.63 | 0.0% | COM NEW | 98420X202 |
| IKT | INHIBIKASE THERAPEUTICS INC | 28,453 | $58,328 | 1.4% | $2.11 | -24.6% | COM NEW | 45719W205 |
| SABS | SAB BIOTHERAPEUTICS INC | 10,527 | $39,371 | 0.9% | $2.26 | +45.5% | COM NEW | 78397T202 |
| CNTX | CONTEXT THERAPEUTICS INC | 18,403 | $27,053 | 0.6% | $1.72 | -32.2% | COM | 21077P108 |